Skip to main content

Table 1 Baseline demographic and clinical characteristics of participants N = 158

From: Patients’ confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC)

Variable All patients with DSE (n = 158) SABR (n = 73) Surgery (n = 85)
Treatment (surgery, %) 85 (53.8)   
Gender (male, %) 69 (43.6) 26 (35.6) 43 (50.5)
Age (years, SD) 72.4 (8.6) 74.5 (9.3) 70.5 (7.5)
Comorbidity (yes, %) 135 (85.4) 67 (91.7) 68 (80)
FEV1% (SD) 83.5 (25.1) 75.5 (27.4) 89.2 (21.8)
DLCO% (SD) 77.6 (22.2) 69.6 (22.8) 83.5 (19.9)
Currently smoking (n, %) 34 (22.6%) 19 (27.1) 15 (18.7)
PS > 1 (n, %) 104 (62.4) 39 (53.4) 15 (17.6)
DSE (Mean, SD) 81.7 (23) 79.5 (23) 83.6 (22.9)
  1. Results are expressed as mean and standard deviation (SD) for numeric variables and as count and percentages for categorical variables. FEV1: forced expiratory volume in 1 second; diffusing capacity of the lung for carbon monoxide (DLCO) expressed in percentage of predicted value, Eastern Cooperative Oncology Group Performance Status (PS).